140 related articles for article (PubMed ID: 35884998)
1. Mapping the Serum Proteome of COVID-19 Patients; Guidance for Severity Assessment.
Nuñez E; Orera I; Carmona-Rodríguez L; Paño JR; Vázquez J; Corrales FJ
Biomedicines; 2022 Jul; 10(7):. PubMed ID: 35884998
[TBL] [Abstract][Full Text] [Related]
2. Targeted proteomics identifies circulating biomarkers associated with active COVID-19 and post-COVID-19.
Zoodsma M; de Nooijer AH; Grondman I; Gupta MK; Bonifacius A; Koeken VACM; Kooistra E; Kilic G; Bulut O; Gödecke N; Janssen N; Kox M; Domínguez-Andrés J; van Gammeren AJ; Ermens AAM; van der Ven AJAM; Pickkers P; Blasczyk R; Behrens GMN; van de Veerdonk FL; Joosten LAB; Xu CJ; Eiz-Vesper B; Netea MG; Li Y
Front Immunol; 2022; 13():1027122. PubMed ID: 36405747
[TBL] [Abstract][Full Text] [Related]
3. Re-analysis of SARS-CoV-2-infected host cell proteomics time-course data by impact pathway analysis and network analysis: a potential link with inflammatory response.
Bock JO; Ortea I
Aging (Albany NY); 2020 Jun; 12(12):11277-11286. PubMed ID: 32575076
[TBL] [Abstract][Full Text] [Related]
4. Insights into COVID-19 Vaccine Development Based on Immunogenic Structural Proteins of SARS-CoV-2, Host Immune Responses, and Herd Immunity.
Chaudhary JK; Yadav R; Chaudhary PK; Maurya A; Kant N; Rugaie OA; Haokip HR; Yadav D; Roshan R; Prasad R; Chatrath A; Singh D; Jain N; Dhamija P
Cells; 2021 Oct; 10(11):. PubMed ID: 34831172
[TBL] [Abstract][Full Text] [Related]
5. The serum of COVID-19 asymptomatic patients up-regulates proteins related to endothelial dysfunction and viral response in circulating angiogenic cells ex-vivo.
Beltrán-Camacho L; Eslava-Alcón S; Rojas-Torres M; Sánchez-Morillo D; Martinez-Nicolás MP; Martín-Bermejo V; de la Torre IG; Berrocoso E; Moreno JA; Moreno-Luna R; Durán-Ruiz MC
Mol Med; 2022 Apr; 28(1):40. PubMed ID: 35397534
[TBL] [Abstract][Full Text] [Related]
6. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
7. Kinetic Multi-omic Analysis of Responses to SARS-CoV-2 Infection in a Model of Severe COVID-19.
Cantwell AM; Singh H; Platt M; Yu Y; Lin YH; Ikeno Y; Hubbard G; Xiang Y; Gonzalez-Juarbe N; Dube PH
J Virol; 2021 Sep; 95(20):e0101021. PubMed ID: 34319784
[TBL] [Abstract][Full Text] [Related]
8. Human and novel coronavirus infections in children: a review.
Rajapakse N; Dixit D
Paediatr Int Child Health; 2021 Feb; 41(1):36-55. PubMed ID: 32584199
[TBL] [Abstract][Full Text] [Related]
9. Alterations in the Plasma Proteome Induced by SARS-CoV-2 and MERS-CoV Reveal Biomarkers for Disease Outcomes for COVID-19 Patients.
Alaiya A; Alshukairi A; Shinwari Z; Al-Fares M; Alotaibi J; AlOmaim W; Alsharif I; Bakheet R; Alharbi L; Allam R; Asiri A; Memish Z; Alromaih K; Al-Mozaini M
J Inflamm Res; 2021; 14():4313-4328. PubMed ID: 34511970
[TBL] [Abstract][Full Text] [Related]
10. Immuno-Informatics Quest against COVID-19/SARS-COV-2: Determining Putative T-Cell Epitopes for Vaccine Prediction.
Akhtar N; Joshi A; Singh B; Kaushik V
Infect Disord Drug Targets; 2021; 21(4):541-552. PubMed ID: 32957905
[TBL] [Abstract][Full Text] [Related]
11. Longitudinal Serum Proteome Characterization of COVID-19 Patients With Different Severities Revealed Potential Therapeutic Strategies.
Wu S; Xu Y; Zhang J; Ran X; Jia X; Wang J; Sun L; Yang H; Li Y; Fu B; Huang C; Liao P; Sun W
Front Immunol; 2022; 13():893943. PubMed ID: 35958562
[TBL] [Abstract][Full Text] [Related]
12. Third Wave of the COVID-19 Pandemic: Prominence of Initial Public Health Interference.
Mukherjee S; Ray SK
Infect Disord Drug Targets; 2022; 22(4):e080222200919. PubMed ID: 35135456
[TBL] [Abstract][Full Text] [Related]
13. Ubiquitin-Modified Proteome of SARS-CoV-2-Infected Host Cells Reveals Insights into Virus-Host Interaction and Pathogenesis.
Zhang H; Zheng H; Zhu J; Dong Q; Wang J; Fan H; Chen Y; Zhang X; Han X; Li Q; Lu J; Tong Y; Chen Z
J Proteome Res; 2021 May; 20(5):2224-2239. PubMed ID: 33666082
[TBL] [Abstract][Full Text] [Related]
14. Proteomics and Machine Learning Approaches Reveal a Set of Prognostic Markers for COVID-19 Severity With Drug Repurposing Potential.
Suvarna K; Biswas D; Pai MGJ; Acharjee A; Bankar R; Palanivel V; Salkar A; Verma A; Mukherjee A; Choudhury M; Ghantasala S; Ghosh S; Singh A; Banerjee A; Badaya A; Bihani S; Loya G; Mantri K; Burli A; Roy J; Srivastava A; Agrawal S; Shrivastav O; Shastri J; Srivastava S
Front Physiol; 2021; 12():652799. PubMed ID: 33995121
[TBL] [Abstract][Full Text] [Related]
15. COVID-19: a conundrum to decipher.
Deshmukh V; Tripathi SC; Pandey A; Deshmukh V; Vykoukal J; Patil A; Sontakke B
Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5830-5841. PubMed ID: 32495923
[TBL] [Abstract][Full Text] [Related]
16. Virus-Host Interactome and Proteomic Survey Reveal Potential Virulence Factors Influencing SARS-CoV-2 Pathogenesis.
Li J; Guo M; Tian X; Wang X; Yang X; Wu P; Liu C; Xiao Z; Qu Y; Yin Y; Wang C; Zhang Y; Zhu Z; Liu Z; Peng C; Zhu T; Liang Q
Med; 2021 Jan; 2(1):99-112.e7. PubMed ID: 32838362
[TBL] [Abstract][Full Text] [Related]
17. Pathogenesis-directed therapy of 2019 novel coronavirus disease.
Stratton CW; Tang YW; Lu H
J Med Virol; 2021 Mar; 93(3):1320-1342. PubMed ID: 33073355
[TBL] [Abstract][Full Text] [Related]
18. Pathological features of COVID-19-associated lung injury: a preliminary proteomics report based on clinical samples.
Leng L; Cao R; Ma J; Mou D; Zhu Y; Li W; Lv L; Gao D; Zhang S; Gong F; Zhao L; Qiu B; Xiang H; Hu Z; Feng Y; Dai Y; Zhao J; Wu Z; Li H; Zhong W
Signal Transduct Target Ther; 2020 Oct; 5(1):240. PubMed ID: 33060566
[TBL] [Abstract][Full Text] [Related]
19. Proteomics reveals antiviral host response and NETosis during acute COVID-19 in high-risk patients.
Bauer A; Pachl E; Hellmuth JC; Kneidinger N; Heydarian M; Frankenberger M; Stubbe HC; Ryffel B; Petrera A; Hauck SM; Behr J; Kaiser R; Scherer C; Deng L; Teupser D; Ahmidi N; Muenchhoff M; Schubert B; Hilgendorff A
Biochim Biophys Acta Mol Basis Dis; 2023 Feb; 1869(2):166592. PubMed ID: 36328146
[TBL] [Abstract][Full Text] [Related]
20. Proteo-Genomic Analysis of SARS-CoV-2: A Clinical Landscape of Single-Nucleotide Polymorphisms, COVID-19 Proteome, and Host Responses.
Tushir S; Kamanna S; Nath SS; Bhat A; Rose S; Aithal AR; Tatu U
J Proteome Res; 2021 Mar; 20(3):1591-1601. PubMed ID: 33555895
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
